Pancreas Cyst, Pancreas Disease, Pancreas Neoplasm, Pancreatic Cancer
Conditions
Brief summary
The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.
Detailed description
Single center, observational (retrospective and prospective) will collect all available parameters to assess the clinical outcome of the patients (progression free survival (PFS), overall survival (OS), local progression free survival LTPFS), response to treatment) with pancreatic neoplasms presenting to San Raffaele. Patient assignment to a given diagnostic and/or therapeutic procedure is not related to random assignment methods but is part of the ordinary therapeutic strategy planned for each patient on an individual basis and after multidisciplinary discussion.
Interventions
OTHERRadiology evaluations and interventions
Diagnostic and interventional radiology procedures
Sponsors
IRCCS San Raffaele
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* ≥18 years of age * Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage. * able and willing to sign informed consent
Exclusion criteria
* Patients with non-primary pancreatic disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Progression- free survival | From date of intervention until the date of first documented progression, up to a maximum of 3 years | Time from start of observation to disease progression |
| Local progression free survival | From date of intervention until the date of first documented local progression assessed up to a maximum of 3 years | Time between (start of) a locoregional treatment and local disease progression |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Overall Survival | From date of treatment until the date of death from any cause assessed up to 3 years | The length of time from either the date of diagnosis or the start of treatment for a disease, in which the patients are still alive |
Countries
Italy
Outcome results
None listed